John W. Beck, Chief Financial Officer at METABASIS THERAPEUTICS INC (MBRX), sold 10,035 shares at $8.01 ($80K) on 2007-06-01, disclosed to the SEC on 2007-06-05.
Scheduled sale ($80k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 9,635 | $77K | 96.0% |
| 2 | $8.01 | 400 | $3K | 4.0% |
| Total | $8.00 avg | 10,035 | $80K | 100% |
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |